Popular Articles

Funding Allocated For Hospice Care, Wales
Health Minister Edwina Hart announced the allocation of ÷£4million Assembly Government funding for hospices and palliative care services across Wales.

Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk For Stage II Colon Cancer Patients
Genomic Health, Inc. (Nasdaq: GHDX) announced positive results from the landmark QUASAR validation study, which demonstrated that the Oncotype DX(R) colon cancer test can independently predict individual recurrence risk in stage II colon cancer patients following surgery. Importantly, the Oncotype DX colon cancer Recurrence Score(R) provided additional independent clinical value beyond standard measures. The study showed that the colon cancer Recurrence Score maintained significance (p=0.008), independent of mismatch repair (MMR), also known as MSI (Microsatellite Instability), T-stage, nodes examined, grade and lymphovascular invasion.
News of the day
Gates Foundation Donates Additional $80M To Indian HIV-Prevention Program, Receives Indira Gandhi Prize For Peace, Disarmament And Development
The Bill & Melinda Gates Foundation will give an additional $80 million to Avahan, a foundation initiative launched in 2003 for HIV prevention programs in India, Bill Gates said on Thursday, the Seattle Times blog, "Business of Giving" reports. Previous foundation commitments to the program, "which involves more than 100 non-profits in six Indian states," total $258 million, the blog writes (Heim, 7/23).
Oncology

An Amnesic Patient With An Extraordinary Distorted Memory

If somebody asks you "Do you remember what you did on March 13, 1985?" you are very likely to answer "I don"t know", even if your memory is excellent. In a study conducted by Dalla Barba and Decaix from the Institut National de la Santçİ et de la Recherche Mçİdicale and the Department of Neurology of the Hç´pital Saint Antoine in Paris and published by Elsevier in the May 2009 issue of Cortex, researchers found that a patient with severe amnesia reported detailed false memories in answering this type of question. People with normal memories are unable to answer this type of question because it is beyond their memory capacity. This is the first reported case of a pathological condition that the authors of the article named "Confabulatory Hyperamnesia". Patient LM, described in this study, is a 68-year-old man, who, following more than 30 years of heavy drinking, developed Korsakoff"s syndrome, a condition characterized by severe amnesia and confabulation, the unintentional production of false memories by amnesic patients who are unaware of their memory deficits. Patients who confabulate produce more or less plausible false memories answering questions like "What did you do yesterday?" or "How did you spend your last vacation?", but, just like people with normal memory, they answer "I don"t know" to questions like "Do you remember what you did on March 13, 1985". What makes LM different from other confabulators is his unusual tendency to consistently provide a confabulatory answer to this type of questions. He would say, for example, that on March 13, 1985 he spent the day at the Senart Forest (a place where he used to go often with his family) or that he could remember that on the first day of summer in 1979 he was wearing shorts and a T-shirt. LM"s confabulatory hyperamnesia could not be traced back to any specific pattern of brain damage and the MRI brain scan was unremarkable. The authors conclude that LM shows an expanded consciousness of his past, a consciousness which has surpassed the limits of time and details. The article is "Do you remember what you did on March 13, 1985?" A case study of confabulatory hyperamnesia" by Gianfranco Dalla Barba and Caroline Dacaix and appears in Cortex, Volume 45, Issue 5 (May 2009), published by Elsevier in Italy. Valeria Brancolini Elsevier


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):